Correction to: A novel melittin nano-liposome exerted excellent anti-hepatocellular carcinoma efficacy with better biological safety

Affiliations

• ¹ State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Disease, Center for New Drug Safety Evaluation and Research, China Pharmaceutical University, Nanjing, 211198, China.
• ² The Second Hospital of Nanjing, Nanjing, 320100, China.
• ³ School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
• ⁴ State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Disease, Center for New Drug Safety Evaluation and Research, China Pharmaceutical University, Nanjing, 211198, China. [email protected].
• ⁵ Institute of Pharmaceutical Science, China Pharmaceutical University, No 639, Longmian Rd., Nanjing, 211198, China. [email protected].
• ⁶ State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Drug Discovery for Metabolic Disease, Center for New Drug Safety Evaluation and Research, China Pharmaceutical University, Nanjing, 211198, China. [email protected].
• ⁷ Institute of Pharmaceutical Science, China Pharmaceutical University, No 639, Longmian Rd., Nanjing, 211198, China. [email protected].